Evidence map›Paper›PMID 27531364›Full record

ArticleInflammation2016

The P2X7 Receptor Involved in gp120-Induced Cell Injury in BV2 Microglia.

Qiang Chen, Hui Wu, Shanshan Qin, Chenglong Liu, Yue Chen, Yajie Yang, Changshui Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. P2RX7 at the Host-Pathogen Interface of Infectious Diseases.Microbiology and molecular biology reviews : MMBR · 2021
    Review
  9. Review
  10. Review
  11. P2X7 Receptor Antagonist A804598 Inhibits Inflammation in Brain and Liver in C57BL/6J Mice Exposed to Chronic Ethanol and High Fat Diet.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qiang ChenDepartment of Physiology, Basic Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
Hui WuThe Second Clinical Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
Shanshan QinDepartment of Physiology, Basic Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
Chenglong LiuDepartment of Physiology, Basic Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
Yue ChenThe Second Clinical Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
Yajie YangThe First Clinical Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
Changshui XuDepartment of Physiology, Basic Medical College, Nanchang University, Nanchang, 330006, People's Republic of China. xuchangshui@ncu.edu.cn.ORCID http://orcid.org/0000-0002-3928-3605
Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was aimed at exploring the effects of P2X7 receptor on BV2 microglia cell injury induced by glycoprotein gp120 (gp120) and its underlying mechanisms. We used the MTS method to study the influence of different gp120 concentrations on BV2 microglia cells, and to test the degree of cell injury in each gp120 treatment group; quantitative real-time PCR (qPCR) and Western blot were used to detect the P2X7 mRNA and receptor protein expressions. Immunocytochemistry and Western blot were used to detect the P2X7 receptor expression and P65 NF-κB, respectively. We also measured the content of TNFα, IL-1β, nitric oxide (NO) and reactive oxygen species (ROS). We found that the cell survival rate generally decreased as gp120 concentration increased, and the cell survival rate of the gp120 + Brilliant Blue G (BBG) group was higher than that of the gp120 group. Western blot and qPCR results showed that the expressions of P2X7 receptor protein and mRNA were positively dose-dependent with gp120 concentration; the results of immunocytochemistry and Western blot showed that the expressions of P2X7 receptor and P65 NF-κB in the gp120 group increased significantly compared to those of the control (Ctrl) group, but those in the gp120+BBG group decreased. Taken together, these results confirmed that the P2X7 receptor is involved in gp120-induced BV2 microglial cell injury and that the underlying mechanism may be associated with the over-activation of microglia caused by P2X7 receptor up-regulation, which leads to abundant release of inflammatory factors which exert toxic effects on the cells.

Indexed as

AnimalsCell SurvivalDose-Response Relationship, DrugHIV Envelope Protein gp120Immunologic FactorsMiceMicrogliaReceptors, Purinergic P2X7RNA, MessengerTranscription Factor RelAgp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120Immunologic FactorsReceptors, Purinergic P2X7RNA, MessengerTranscription Factor RelABV2 microgliaCell injurygp120P2X7 receptor

Identifiers

PMID27531364
OpenAlexW2512331882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.